430 related articles for article (PubMed ID: 28687674)
1. Anti-inflammatory ω-3 endocannabinoid epoxides.
McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A
Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674
[TBL] [Abstract][Full Text] [Related]
2. Novel Anti-inflammatory and Vasodilatory ω-3 Endocannabinoid Epoxide Regioisomers.
Carnevale LN; Das A
Adv Exp Med Biol; 2019; 1161():219-232. PubMed ID: 31562632
[TBL] [Abstract][Full Text] [Related]
3. [Fatty acid epoxides in the regulation of the inflammation].
Kytikova OY; Denisenko YK; Novgorodtseva TP; Bocharova NV; Kovalenko IS
Biomed Khim; 2022 Jun; 68(3):177-189. PubMed ID: 35717582
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
6. Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.
Roy J; Watson JE; Hong IS; Fan TM; Das A
J Med Chem; 2018 Jul; 61(13):5569-5579. PubMed ID: 29856219
[TBL] [Abstract][Full Text] [Related]
7. Emerging class of omega-3 fatty acid endocannabinoids & their derivatives.
Watson JE; Kim JS; Das A
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106337. PubMed ID: 31085370
[TBL] [Abstract][Full Text] [Related]
8. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
10. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.
Arnold C; Markovic M; Blossey K; Wallukat G; Fischer R; Dechend R; Konkel A; von Schacky C; Luft FC; Muller DN; Rothe M; Schunck WH
J Biol Chem; 2010 Oct; 285(43):32720-32733. PubMed ID: 20732876
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ω-3 and ω-6 PUFAs.
Cho C; Aliwarga T; Wiley AM; Totah RA
Adv Pharmacol; 2023; 97():201-227. PubMed ID: 37236759
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma.
Leineweber CG; Pietzner A; Zhang IW; Blessin UB; Rothe M; Schott E; Schebb NH; Weylandt KH
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182938
[TBL] [Abstract][Full Text] [Related]
13. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
Frömel T; Hu J; Fleming I
Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
[TBL] [Abstract][Full Text] [Related]
14. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.
Spector AA; Kim HY
Biochim Biophys Acta; 2015 Apr; 1851(4):356-65. PubMed ID: 25093613
[TBL] [Abstract][Full Text] [Related]
16. [Essential fatty acids and lipid mediators. Endocannabinoids].
Caramia G
Pediatr Med Chir; 2012; 34(2):65-72. PubMed ID: 22730630
[TBL] [Abstract][Full Text] [Related]
17. The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.
Ghanbari MM; Loron AG; Sayyah M
Brain Res Bull; 2021 May; 170():74-80. PubMed ID: 33581310
[TBL] [Abstract][Full Text] [Related]
18. The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation.
de Bus I; Witkamp R; Zuilhof H; Albada B; Balvers M
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106351. PubMed ID: 31260750
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids.
Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
Clin Sci (Lond); 2021 Jan; 135(1):185-200. PubMed ID: 33393630
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation.
Jung F; Schulz C; Blaschke F; Muller DN; Mrowietz C; Franke RP; Lendlein A; Schunck WH
Clin Hemorheol Microcirc; 2012; 52(2-4):403-16. PubMed ID: 22975950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
